Stock GRTX GALERA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Galera Therapeutics, Inc.

Equities

GRTX

US36338D1081

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
0.1861 USD -10.31% Intraday chart for Galera Therapeutics, Inc. +1.14% +27.99%
04-03 North American Morning Briefing : Powell Awaited -2- DJ
03-28 Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : Powell Awaited -2-
DJ
Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Galera Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
GL
Galera Therapeutics : Failure to Satisfy Listing Rule - Form 8-K
PU
North American Morning Briefing : Markets on Hold -2-
DJ
North American Morning Briefing : Stock Futures -2-
DJ
Galera Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
GL
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
AQ
Galera Therapeutics Announces Review of Strategic Alternatives
CI
Galera Shares Halted After FDA Says Avasopasem Needs Additional Phase 3 Trial
DJ
Galera Therapeutics, Inc. Announces Receipt of Type A Meeting Minutes and Strategic Update
CI
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
GL
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
AQ
Galera Therapeutics : Failure to Satisfy Listing Rule - Form 8-K
PU
Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem
GL
Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
GL
North American Morning Briefing : Treasury Yields -2-
DJ
HC Wainwright Downgrades Galera Therapeutics to Neutral From Buy, Adjusts Price Target to $0.30 From $6
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GRTX Stock
  4. News Galera Therapeutics, Inc.